BACKGROUND: Oncogenous osteomalacia (OOM), which is also known as tumour-induced osteomalacia, is a rare condition associated with a neoplasm and a related systemic bone demineralization caused by renal phosphate wasting. OOM usually occurs in association with a variety of different mesenchymal tumours, and they were categorized into four distinct morphological patterns which they termed "phosphaturic mesenchymal tumour". Of its 4 histopathological subtypes, the mixed connective tissue variant is most commonly observed. Only 10% of cases appear in the head and neck regions and moreover, only 5 previously published tumors were localized in the sinonasal area. The authors describe a case of a man with a PMT originating from the frontoethmoidal region. CASE PRESENTATION: A 53-year-old man was referred to our ORL clinic due to a presence of a mass at the nasal root having been growing asymptomatically for 1 year. CT scans demonstrated a large (25 × 20 × 35 mm) bilateral frontoethmoidal mass with destruction of nasal bones. The tumor did not appear to invade to the anterior skull base. A selective angiography revealed a moderate hypervascularization of the tumour during early and late arterial phases. The tumour was removed from the external approach and the definitive histopathological diagnosis was a phospaturic mesenchymal tumor. Dual energy X-ray absorptiometry revealed a slight osteopenia of the first and second lumbar vertebrae and neck of the thigh bone. The serum and urinary levels of both calcium and anorganic phosphate were within normal limits. The patient is doing well three years after the operation, and the serum and urine levels of calcium and phosphate remain well within normal limits. CONCLUSION: PMT is rare in the sinonasal region, it can be rarely observed without the signs of osteomalacia.

Department of Otorhinolaryngology University Hospital Ostrava Czech Republic

Zobrazit více v PubMed

McCance RA. Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to Vitamin D acquired about the age of 15 years. Quart J Med. 1947;16:33–46. PubMed

Koriyama N, Nishimoto K, Kodama T. et al.Oncogenic osteomalacia in a case with maxillary sinus mesenchymal tumor. J Med Sci. 2006;332(4):141–147. PubMed

Williams K, Flanagan A, Folpe A. et al.Lymphatic vessels are present in phosphaturic mesenchymal tumours. Wirchows Arch. 2007;451:871–875. doi: 10.1007/s00428-007-0471-y. PubMed DOI

Weidner N, Santa Cruz D. Phosphaturic mesenchymal tumours. A polymorphous group causing osteomalacia or rickets. Cancer. 1987;59:1442–1454. doi: 10.1002/1097-0142(19870415)59:8<1442::AID-CNCR2820590810>3.0.CO;2-Q. PubMed DOI

Folpe AL, Fanburg-Smith JC, Billlings SD. et al.Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity, the "phosphaturic mesenchymal tumor, mixed connective tissue variant": An analysis of 32 cases and a comprehensive review of the literature. Am J Surg. 2004;28:1–30. doi: 10.1097/00000478-200401000-00001. PubMed DOI

Gonzales-Compta X, Manos-Pujol M, Foglia-Fernandez M. et al.Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol. 1998;112:389–392. PubMed

Yun KI, Kim DH, Pyo SW. A Phosphaturic mesenchymal tumor of the floor of the mouth with oncognic osteomalacia: report of a case. J Oral Maxillofac Surg. 2009;67:402–405. doi: 10.1016/j.joms.2008.01.007. PubMed DOI

Linsey M, Smith W, Yamauchi H, Bernstein L. Nasopharyngeal angiofibroma presenting as adult osteomalacia: case report and review of the literature. Laryngoscope. 1983;93:1328–1331. PubMed

Papotti M, Foschini MP, Isaia G, Rizzi G, Betts CM, Eusebi V. Hypophosphatemic oncogenic osteomalacia: report of three new cases. Tumori. 1988;74:599–607. PubMed

Kawai Y, Morimoto S, Sakaguchi K, Yoshino H, Yutsui T, Hirota S. et al.Oncogenic osteomalacia secondary to nasal tumor with decreased urinary excertion of cAMP. J Bone Miner Metab. 2001;19:61–64. doi: 10.1007/s007740170062. PubMed DOI

Shimada T, Mizutani S, Muto T. et al.Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Ntl Acad Sci USA. 2001;98:6500–6505. doi: 10.1073/pnas.101545198. PubMed DOI PMC